Loading...
Kindstar Globalgene Technology, Inc.
9960.HK•HKSE
Healthcare
Medical - Care Facilities
HK$1.52
HK$0.02(1.33%)
Kindstar Globalgene Technology, Inc. (9960.HK) Financial Performance & Income Statement Overview
Review Kindstar Globalgene Technology, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-4.10%
↓ 4.10%
Operating Income Growth
-14.61%
↓ 14.61%
Net Income Growth
-232.22%
↓ 232.22%
Operating Cash Flow Growth
100.00%
↑ 100.00%
Operating Margin
-5.25%
↓ 5.25%
Gross Margin
47.39%
↑ 47.39%
Net Profit Margin
-5.89%
↓ 5.89%
ROE
-1.92%
↓ 1.92%
ROIC
-1.67%
↓ 1.67%
Kindstar Globalgene Technology, Inc. (9960.HK) Income Statement & Financial Overview
Review Kindstar Globalgene Technology, Inc.'s (9960.HK) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $227.12M | $227.12M | $236.67M | $236.67M |
| Cost of Revenue | $120.23M | $120.23M | $123.77M | $123.77M |
| Gross Profit | $106.89M | $106.89M | $112.89M | $112.89M |
| Gross Profit Ratio | $0.47 | $0.47 | $0.48 | $0.48 |
| R&D Expenses | $28.70M | $28.70M | $24.20M | $24.20M |
| SG&A Expenses | $93.87M | $93.87M | $97.34M | $97.34M |
| Operating Expenses | $122.57M | $122.57M | $121.55M | $121.55M |
| Total Costs & Expenses | $242.80M | $242.80M | $245.32M | $245.32M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $12.58M | $12.01M | $12.01M | $12.01M |
| EBITDA | -$52.64M | -$53.20M | -$5.56M | -$5.56M |
| EBITDA Ratio | -$0.23 | -$0.23 | -$0.02 | -$0.02 |
| Operating Income | -$15.69M | -$15.69M | -$8.65M | -$8.65M |
| Operating Income Ratio | -$0.07 | -$0.07 | -$0.04 | -$0.04 |
| Other Income/Expenses (Net) | -$19.94M | -$19.94M | $16.18M | $16.18M |
| Income Before Tax | -$35.63M | -$35.63M | $7.53M | $7.53M |
| Income Before Tax Ratio | -$0.16 | -$0.16 | $0.03 | $0.03 |
| Income Tax Expense | $25000.00 | $25000.00 | $2.27M | $2.27M |
| Net Income | -$33.24M | -$33.24M | $5.95M | $5.95M |
| Net Income Ratio | -$0.15 | -$0.15 | $0.03 | $0.03 |
| EPS | -$0.04 | -$0.04 | $0.006 | $0.006 |
| Diluted EPS | -$0.04 | -$0.04 | $0.006 | $0.006 |
| Weighted Avg Shares Outstanding | $941.61M | $941.61M | $959.27M | $959.27M |
| Weighted Avg Shares Outstanding (Diluted) | $941.58M | $941.58M | $955.48M | $955.48M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan